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1015-9584/Copyright ª 2014, Asian SuSummary Background: Inappropriate skin incisions can make sentinel lymph node dissection
difficult. A knowledge of the most common locations of the hotspot in the axilla helps in plan-
ning the incision. This information also helps to locate the lymph node preoperatively by ultra-
sound. The aim of this prospective study was to determine the most common location of the
sentinel lymph node in the axilla.
Methods: From January 2006 to December 2010, 974 consecutive patients who underwent
sentinel lymph node dissection guided by 99mTcesulfur colloid were included and the position
of the hotspot in the axilla was recorded prospectively. The location of the hottest spot on the
skin of the axilla was categorized into seven areas divided by five landmarks.
Results: In 98.4% of our patients, the hotspot detected on the axilla skin before sentinel lymph
node dissection was located in the area demarcated by the four landmarks of the hairline, a
line tangential to and 2 cm below the center of the hairline, the lateral border of the pectoralis
major muscle, and the mid-axillary line.
Conclusion: The area between these four landmarks is the most frequent location of the
sentinel lymph node identified using the radioisotope method. We suggest that this area should
be carefully evaluated preoperatively by ultrasound for appropriate surgical planning. A skin
incision in this area is also recommended when sentinel lymph node dissection is guided by
blue dye.
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Figure 1 Position of the patient with arm abduction from the
chest wall of around 105, 15 flexion, and elbow flexion, with
a soft pad to elevate the arm. The red cross denotes the
location of the sentinel lymph node detected preoperatively by
gamma probe; the blue circle shows the sentinel lymph node
detected by radioisotope scintigraphy. The three black lines
indicate the lateral edge of the pectoralis major muscle, the
hairline, and the lateral edge of the latissimus dorsi muscle
(from upper to lower, respectively).
Figure 2 Schematic diagram showing the five landmarks on
the skin of the axilla.
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Axillary lymph node status is the most important prog-
nostic factor in patients with breast cancer. Sentinel
lymph node dissection (SLND) is now replacing axillary
lymph node dissection for the determination of axillary
lymph node status in patients with breast cancer without
palpable axillary lymph nodes.1e4 SLND can be guided by
radioisotopes or by blue dye, or both. When SLND is guided
by radioisotope, the incision can be made over the hottest
spot in the axilla; when it is guided by blue dye, the
incision is usually made about 1e2 cm below the hairline
in the axilla.5,6 Because an inappropriate incision can
make intraoperative lymphatic mapping difficult, espe-
cially when using the blue dye method,5 a knowledge of
the most common location of the hotspot in the axilla
during radioisotope-guided SLND should not only help to
plan the incision for SLND guided by blue dye, but also
help to locate the lymph node preoperatively by
ultrasound.
The aim of this prospective study was to determine the
most common location of the sentinel lymph node (SLN) in
the axilla as shown by the hottest spot on the skin in the
axilla after periareolar injection of radioactive colloid.
2. Methods
From January 2006 to December 2010, all consecutive pa-
tients who underwent SLND performed by the same surgeon
(C.-S.H.) in the National Taiwan University Hospital were
included in this study. Patients with previous neoadjuvant
chemotherapy were excluded. The SLND information,
including the position of the hotspot in the axilla, was
recorded prospectively.
The SLN biopsy procedure was guided by a 99mTcesulfur
colloid with intradermal periareolar injection in the quad-
rant where the tumor was located.7 Two protocols for
radioactive colloid injection were used. In the 2-day pro-
tocol, 2 mCi of filtered (0.22 mm) 99mTcesulfur colloid were
injected in the afternoon 1 day before the operation. In the
1-day protocol, 1 mCi of filtered 99mTcesulfur colloid was
injected on the morning of the day of the operation.
The patients were all placed in a saluting position during
surgery (i.e. arm abduction from the chest wall about 105,
flexion 15, and elbow flexion) with a soft pad to elevate
the arm (Fig. 1). In this position, the axillary area was
divided into seven areas divided by five landmarks, which
were labeled A to E. Landmark A was the lowest part of the
hair-bearing area (hairline); B was the line drawn tangential
to, and 2 cm below, the center of landmark A; C was the
mid-axillary line which crosses the center point of the
hairline; D was the lateral edge of the pectoralis major
muscle; and E was the lateral edge of the latissimus dorsi
muscle (Fig. 2). Location 1 was the area surrounded by A, B,
C, and D. Location 2 indicated the point of intersection of B
and C. Location 3 was the point of intersection of A and C.
Location 4 was the area surrounded by A, B, C, and E.
Location 5 was the area between C, E and the area above
line A. Location 6 was the point on line C, 2 cm away from
location 3 cephalically. Location 7 was the area between C,
D and the area above line A (Fig. 3).Before incision, the position of the hottest spot on the
skin of the axilla was detected using a handheld gamma
probe (Navigator GPS, US Surgical, Tyco Healthcare Group,
Norwalk, CT, USA) and assigned to one of these seven areas
(Fig. 3). The position was marked on the skin of the axilla
and the incision was made over the mark.
Figure 3 The seven areas demarcated by the five landmarks
shown in Figure 2.
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During the study period, 1044 consecutive patients under-
went an SLN biopsy procedure in our institution. Of these,
SLND was unsuccessful in 70 patients, who were then
excluded from the study. The remaining 974 patients who
underwent a successful SLN biopsy procedure were
included in this study.
The hottest node was detected at location 1 in 356 pa-
tients (36.6%), location 2 in 531 patients (54.5%), location 3
in 71 patients (7.3%), location 4 in one patient (0.1%),
location 6 in one patient (0.1%), and location 7 in 14 pa-
tients (1.4%). No patient had the hottest spot at location 5.
Overall, in 958 patients (98.4%), the hottest spot was at
location 1, 2, or 3.4. Discussion
In 98.4% of patients, the hottest spot detected on the axilla
skin before SLND, identified by intradermal periareolar in-
jection of radioisotope, was located in the area demar-
cated by the hairline, a line tangential to and 2 cm below
the center of the hairline, the lateral border of the pec-
toralis major muscle, and the mid-axillary line. This infor-
mation will be helpful in planning the incision for SLND
guided by blue dye, as inappropriate incisions can make
intraoperative lymphatic mapping difficult.Giuliano et al8 first introduced SLND in patients with
breast cancer in 1994 using the blue dye method and sug-
gested a transverse incision just below the hair-bearing
region of the axilla. Later, Dauway et al5 recommended
making the incision 1 cm below the hair-bearing area. A
blue node may be difficult to identify when it is covered by
a substantial layer of fat9 and a knowledge of the most
frequent location of the hottest spot on the axilla skin,
indicating the location of the SLN, should help surgeons
plan the incision for SLND and find the SLN. According to our
data, a small incision can be made at the center of the area
delineated by the hairline, the mid-axillary line, the edge
of the pectoralis major muscle, and a line tangential to and
2 cm below the center of the hairline; 98.4% of SLNs will be
found in locations 1 to 3. The concordance between the
blue dye and radioisotope methods for the positive location
of SLNs is 94.5%.10 We therefore suggest that our approach
can be applied to the blue dye method.
The experienceof the surgeon is an important factor in the
accuracy of SLND.2,11,12 The identification rate is increased to
90e95% and the false negative rate decreased to 3.8e4.3%
when thesurgeonhasperformedmore than30SLNDs.12,13 The
American Society of Breast Surgeons suggests that, before
abandoning theprocedure of carrying out axillary lymphnode
dissection after a negative SLND, SLND followed by axillary
lymph node dissection should have been performed by the
surgeon at least 20 times.14 Knowing the most frequent
location of the SLN may shorten the learning curve for SLND
and avoid unnecessary dissection during the operation.
According to a study by Cox CE,5 94% of SLNs are
detected in a 5 cm diameter area centered on the crossing
of the axillary hairline and the mid-axillary line (Fig. 4). In
our study of 974 SLN biopsy procedures, in 98.4% of patients
the hottest spot was located between the hairline, a line
tangential to and 2 cm below the center of the hairline, the
pectoralis major muscle, and the mid-axillary line. As
shown in Fig. 4, this is a smaller area than that proposed by
Cox CE5 and provides a more precise location of the SLN.
A study by Clough et al15 showed that 98.2% of SLNs are
located alongside the lateral thoracic tributary of the
axillary vein, either below (86.8%) or above (11.5%) the
second intercostobrachial nerve, and no SLN is located in
the area lateral to the lateral thoracic tributary of the
axillary vein and above the intercostobrachial nerve, which
is compatible with the location of hotspots seen before
SLND in our study. This finding of Clough et al15 may help to
avoid causing lymph edema by unnecessary dissection in
this area. However, during an SLN biopsy procedure, the
vessel and motor nerve cannot be visualized. Our finding
may not only help the surgeon to find the blue node,
particularly with a small incision, but also avoid unnec-
essary dissection in other areas.
A human cadaver study16 of the lymphatic anatomy of
the breast showed that tracer injected into either the
subareolar or intradermal location reaches the same first-
tier node close to the lateral edge of the pectoralis minor
muscle. This location is also compatible with our findings.
Preoperative assessment of the axilla by ultrasound is
now widely accepted. If a preoperative ultrasound-guided
biopsy procedure reveals a positive node, SLND may be
avoided. Our finding should also be helpful in locating the
lymph node in the axilla during ultrasound examination.
Figure 4 (A) Schematic diagram of the area in which 94% of
SLNs are located according to Cox CE5 (B) Comparison of this
area (yellow) with the smaller area containing 98.4% of SLNs
determined in our study (blue).
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the site of injection (peritumoral, subdermal, intradermal,
or periareolar) and the SLN identification rate.10,17e20
Suami et al16 suggested that subareolar or intradermal in-
jection might miss other first-echelon nodes that can be
identified by intraparenchymal injection. All the SLND
procedures in our study were performed using intradermal
periareolar injection and whether the results are influ-
enced by the injection site deserves further study.5. Conclusion
In the position of arm abduction from the chest wall of
around 105, flexion 15, and elbow flexion, the most
frequent location of the SLN identified by the radioisotope
method is in the area demarcated by the hairline, a line
tangential to and 2 cm below the center of the hairline, the
pectoralis major muscle, and the mid-axillary line. We
suggest that this area is carefully evaluated preoperativelyby ultrasound for appropriate surgical planning. Once a
positive node is noted preoperatively by ultrasound, then
SLND may be avoided. Because SLND guided by the blue dye
method is still performed worldwide, our findings should
allow surgeons to make a small incision in this area and
avoid the need for incision extension using blue dye
method. If a blue lymph node is hard to identify intra-
operatively, we suggest that the surgeon discloses the area
closest to the pectoralis muscle. We believe this informa-
tion will help shorten the learning curve required for a
breast surgeon to perform SLND and allow easier identifi-
cation of the SLN so that unnecessary dissection can be
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